4 Comments
User's avatar
Sanuj Thomas's avatar

I'm an oncologist in training and I loved reading the article on Keytruda. The race to recreate/produce biosimilars is already on.

Zerodha's avatar

Wow, that’s a nice validation for us :)

Yash Vaishnav's avatar

Please tell me what your research framework for such topics look like - How do you go into so deep in these topics?

I really loved the articles on Copper.

Zerodha's avatar

Hello Yash, Glad you like our work. The simple and the honest answer is that we pick whatever we think is interesting. For more detailed answer, check out this piece we wrote:

https://thedailybrief.zerodha.com/p/how-we-research-at-the-daily-brief